Newsletter

Pol. Merkur. Lek (Pol. Med. J.), 2019, XLVII/279: 114-117 Maximize

Pol. Merkur. Lek (Pol. Med. J.), 2019, XLVII/279: 114-117

Title: Copeptin – a novel biomarker for perioperative homeostasis disorders 

Authors: Mieszczański P, Błaszczyk B, Śmietanowska-Więtczak M, Trzebicki J. 

More details

08/279

40,00 zł

SUMMARY IN POLISH & ENGLISH. FULL ARTICLE ONLY IN POLISH.

Copeptin – a novel biomarker for perioperative homeostasis disorders


Mieszczański P,1 Błaszczyk B,1 Śmietanowska-Więtczak M1,2, Trzebicki J1.

Warsaw Medical University, Poland: 1I Department of Anesthesiology and Intensive Care; 2Chair and Department of Experimental and Clinical Physiology

Recently there has been an increasing amount of research on copeptin as a novel biomarker for stress response and homeostasis disorders in a wide spectrum of morbidities. Copeptin is a stable and easily measured surrogate marker of arginine vasopressin and is increasingly included as a part of routine patient assessment tests in selected clinical scenarios. Such tests are also performed in the perioperative period, in which complication risk assessment is of exceptional importance. This review is an attempt to appraise up to date publications on use of copeptin as a biomarker.

Key words: copeptin, vasopressin, antidiuretic hormone, biomarker, perioperative period

Pol Med J, 2019; XLVII (279); 114–117